Prospective observational study of isoflavone and the risk of stroke recurrence: Potential clinical implications beyond vascular function
- 102 Downloads
Whether isoflavone has any effect on recurrent cardiovascular events is unknown.
To investigate the relations between isoflavone intake and the risk of stroke recurrence.
Subjects and Methods
We recruited 127 consecutive patients with prior history of atherothrombolic/ hemorrhagic stroke (mean age: 67 ± 11 years, 69% male) and prospectively followed up for a mean duration of 30 months. Stroke recurrence and major adverse cardiovascular events (MACE) were documented. Brachial flow-mediated dilatation (FMD) was measured using high-resolution ultrasound. Isoflavone intake was estimated using a validated food frequency questionnaire.
Median isoflavone intake was 6.9 (range: 2.1–14.5) mg/day. Isoflavone intake was independently associated with increased FMD (Pearson R=0.23, p=0.012). At 30 months, there were 10 stroke recurrence and 12 MACE. Kaplan-Meier analysis showed that patients with isoflavone intake higher than median value had significantly longer median stroke recurrence-free survival time (19.0 [range: 10.4–27.6] mth versus 5.0 [range: 4.1–5.9] mth, p=0.021) and MACE-free survival time (19.0 [range: 10.4–27.6] mth versus 4.0 [range: 2.4–5.6] mth, p=0.013). Using multivariate cox regression, higher isoflavone intake was an independent predictor for lower risk of stroke recurrence (hazards ratio 0.18 [95%CI: 0.03–0.95], risk reduction 82%, p=0.043) and MACE (hazards ratio 0.16 [95%CI: 0.03–0.84], risk reduction 84%, p=0.030).
Higher isoflavone intake in stroke patients was associated with prolonged recurrence-free survival, and reduced risk of stroke recurrence and MACE, independent of baseline vascular.function. Whether isoflavone may confer clinically significant secondary protection in stroke patients should be further investigated in a randomized controlled trial.
Key wordsRecurrent stroke isoflavone diet secondary prevention vascular function
Unable to display preview. Download preview PDF.
- 12.Trifiletti A, Gaudio A, Lasco A, Atteritano M, Scamardi R, Pizzoleo MA, Morabito N, Frisina N. Haemostatic effects of phytoestrogen genistein in postmenopausal women. Thromb Res 2008.Google Scholar
- 15.Kokubo Y, Tso H, Tshibara J, Okada K, Inoue M, Tsugane S. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation 2007;116(22):2553–2562.PubMedCrossRefGoogle Scholar
- 16.Adams H, Adams R, Del Zoppo G, Goldstein LB. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36(4):916–923.PubMedCrossRefGoogle Scholar
- 21.Ip MS, Tse HP, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004;169(3):34S–53.Google Scholar
- 24.Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006;114(25):2850–2870.PubMedCrossRefGoogle Scholar